Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Noonan Syndrome 5 × Antineoplastic Agents × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Noonan Syndrome 5 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphoid 1 Early Hormone Receptor-positive Breast Cancer 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

tovorafenib 1 binimetinib 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05566795 2026-03-02

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Day One Biopharmaceuticals, Inc.

Phase 3 Recruiting

Noonan Syndrome 5

Data powered by HemOnc (CC BY 4.0) Colophon ⚡